Related Experiment Video
Updated: Apr 10, 2026

Bronchoalveolar Lavage BAL for Research; Obtaining Adequate Sample Yield
Published on: March 24, 2014
Hypertonic saline for bronchiolitis in infants
Insights
Inhaled hypertonic saline may benefit hospitalized infants with bronchiolitis longer than three days. However, current evidence does not support its routine use in all acute care settings for this common childhood illness.
Area of Science:
- Pediatrics
- Respiratory Medicine
- Infectious Diseases
Background:
- Bronchiolitis is a common viral respiratory infection in infants, frequently requiring hospitalization.
- Respiratory syncytial virus (RSV) is the primary cause of bronchiolitis.
- Hospitalization for bronchiolitis is a significant concern in pediatric acute care.
Purpose of the Study:
- To evaluate the efficacy of inhaled hypertonic saline for bronchiolitis management in pediatric patients.
- To determine if hypertonic saline is recommended for children in the acute care setting.
Main Methods:
- Review of recent studies on nebulized hypertonic saline for bronchiolitis.
- Analysis of treatment outcomes in hospitalized infants.
Main Results:
- Studies on hypertonic saline for bronchiolitis have yielded conflicting results.
- Potential benefits observed in infants hospitalized for over three days.
- Insufficient evidence for widespread recommendation in all acute care settings.
Conclusions:
- Nebulized hypertonic saline may have a role in managing hospitalized bronchiolitis patients beyond three days.
- Routine use of hypertonic saline in acute care for bronchiolitis is not currently recommended due to limited demonstrated benefit.
- Further research may clarify specific indications for hypertonic saline therapy in pediatric bronchiolitis.
Question:
Recently, a 1-year-old patient returned from admission in the hospital for bronchiolitis, and the report I received indicated that he was treated with inhaled hypertonic saline, among other treatments. Is this therapy recommended for children in the acute care setting?
Answer:
Bronchiolitis, caused mostly by respiratory syncytial virus, is very common in the winter. It is the most frequent cause of hospitalization in infancy. Several good studies have been conducted in the past decade on the use of nebulized hypertonic saline for bronchiolitis management; however, they offer conflicting results. While there might be a role for the use of nebulized hypertonic saline in children who are hospitalized with bronchiolitis for more than 3 days, treatment in other settings does not confer enough benefit to recommend its use.
Related Concept Videos
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Inhaled Medications
Antiasthma Drugs: β2-Adrenoceptor Agonists
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Suctioning the Nasopharyngeal Airway
Equipment Required

